The noninflammatory role of high mobility group box 1/toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells

SCA-1 Identifies the Tumor-Initiating Cells in Mammary Tumors of BALB-neuT Transgenic Mice

(2015) Cristina Grange et al.   NEOPLASIA

TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence

(2013) Ilana Chefetz et al.   CELL CYCLE

Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty

(2012) Jeffrey A. Magee et al.   CANCER CELL

STAT3-Driven Upregulation of TLR2 Promotes Gastric Tumorigenesis Independent of Tumor Inflammation

(2012) Hazel Tye et al.   CANCER CELL

Cancer Vaccination Drives Nanog-Dependent Evolution of Tumor Cells toward an Immune-Resistant and Stem-like Phenotype

(2012) K. H. Noh et al.   CANCER RESEARCH

Triple Negative Breast Cancer: From Molecular Portrait to Therapeutic Intervention

(2012) Pietro Carotenuto et al.   CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION

Gene Silencing of Toll-Like Receptor 2 Inhibits Proliferation of Human Liver Cancer Cells and Secretion of Inflammatory Cytokines

(2012) Yuzheng Huang et al.   PLoS One

Role of TLR2-dependent inflammation in metastatic progression

(2011) Sunhwa Kim et al.   Annals of the New York Academy of Sciences

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Regulation of Cancer Stem Cells by Cytokine Networks: Attacking Cancer's Inflammatory Roots

(2011) H. Korkaya et al.   CLINICAL CANCER RESEARCH

NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation

(2011) C R Jeter et al.   ONCOGENE

Important aspects of Toll-like receptors, ligands and their signaling pathways

(2010) Z. L. Chang   INFLAMMATION RESEARCH

The therapeutic promise of the cancer stem cell concept

(2010) Natasha Y. Frank et al.   JOURNAL OF CLINICAL INVESTIGATION

Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands

(2010) Xiaoxia Z. West et al.   NATURE

Bacteria Peptidoglycan Promoted Breast Cancer Cell Invasiveness and Adhesiveness by Targeting Toll-Like Receptor 2 in the Cancer Cells

(2010) Wenjie Xie et al.   PLoS One

Toll-Like Receptor 2 Mediates Proliferation, Survival, NF-κB Translocation, and Cytokine mRNA Expression in LIF-Maintained Mouse Embryonic Stem Cells

(2010) Tammi Taylor et al.   STEM CELLS AND DEVELOPMENT

Targeting the Mechanisms of Resistance to Chemotherapy and Radiotherapy with the Cancer Stem Cell Hypothesis

(2010) Ryan Morrison et al.   Journal of Oncology

Toll-like receptor 2 mediates invasion via activating NF-κB in MDA-MB-231 breast cancer cells

(2009) Wenjie Xie et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature

(2009) Emmanuelle Charafe-Jauffret et al.   CANCER RESEARCH

TLR2 plays a role in the activation of human resident renal stem/progenitor cells

(2009) Fabio Sallustio et al.   FASEB JOURNAL

Blocking TLR2 Activity Attenuates Pulmonary Metastases of Tumor

(2009) Hong-Zhen Yang et al.   PLoS One

HMGB1: a two-headed signal regulating tumor progression and immunity

(2008) Lara Campana et al.   CURRENT OPINION IN IMMUNOLOGY

Microbial Patterns Signaling via Toll-Like Receptors 2 and 5 Contribute to Epithelial Repair, Growth and Survival

(2008) Renat Shaykhiev et al.   PLoS One

Isolation and Molecular Characterization of Cancer Stem Cells in MMTV-Wnt-1Murine Breast Tumors

(2007) Robert W. Cho et al.   STEM CELLS